Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Be a Smart Horse, Not a Workhorse

By Josh Enomoto, InvestorPlace Contributor

Although WKHS stock wins the popularity argument, the reality is that its core competitor has the overall superior solution.

Microvision Isn’t the Best Lidar Play, but It’s One of the Richest

By Josh Enomoto, InvestorPlace Contributor

With MVIS stock worth a ridiculously high premium, investors must wonder about both its sustainability and the industry’s viability.

7 Retail Stocks Hoping for a Sunny Summer Season

By Josh Enomoto, InvestorPlace Contributor

With Covid-19 cases declining and the labor market improving, here are the retail stocks that could benefit from the rebound.

Virgin Galactic Is Cheaper but Is It at a Down-to-Earth Discount?

By Josh Enomoto, InvestorPlace Contributor

While SPCE stock took a beating from its all-time high, you should consider both sides of the story before getting on board.

7 Top Blue-Chip Stocks for the Rest of 2021

By Josh Enomoto, InvestorPlace Contributor

With so much uncertainty clouding the market, you’ll want a healthy serving of these blue-chip stocks in your portfolio.

Positive Spin Isn’t Working for Sarepta Therapeutics

By Josh Enomoto, InvestorPlace Contributor

SRPT stock has some positives going for it but its underlying gene therapy solutions have questions that investors can’t shake.

Fisker Stock Is an Aspirational Bet That Could Be Worth Making Here

By Josh Enomoto, InvestorPlace Contributor

Like other electric vehicle investments, FSR stock has taken a beating but some compelling factors make it a speculative buy.

Aphria’s Global Ambitions Give It Some Heft Ahead of Tilray Tie-up

By Josh Enomoto, InvestorPlace Contributor

APHA stock seems like a compelling buy based on its upcoming merger with Tilray but you should look at the facts before deciding.

7 Hydrogen Stocks for a Greener Portfolio

By Josh Enomoto, InvestorPlace Contributor

While the media is devoting its attention to electric vehicles, hydrogen stocks may offer the key to a cleaner, greener future.

Analyze Senseonics Thoroughly Before You Feed the Meme

By Josh Enomoto, InvestorPlace Contributor

SENS stock is banking on an FDA approval for its diabetes sensor. However, you’ll want to analyze the fundamentals before proceeding.

Load More